Cancer Market Research Reports & Industry Analysis

Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.

Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.

The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.

Found 1367 publications
Vaginal Cancer - Pipeline Review, H2 2016 US$ 2,000.00

... pipeline guide Vaginal Cancer – Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Vaginal Cancer (Oncology), complete with analysis by stage of development ...

Nov, 2016 68 pages
Muscle Invasive Bladder Cancer (MIBC) - Pipeline Review, H2 2016 US$ 2,000.00

... pipeline guide Muscle Invasive Bladder Cancer (MIBC) – Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Muscle Invasive Bladder Cancer (MIBC) (Oncology), complete with analysis by stage of development ...

Nov, 2016 108 pages
Meningioma - Pipeline Review, H2 2016 US$ 2,000.00

... pipeline guide Meningioma – Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Meningioma (Oncology), complete with analysis by stage of development ...

Nov, 2016 68 pages
Gallbladder Cancer - Pipeline Review, H2 2016 US$ 2,000.00

Gallbladder Cancer - Pipeline Review, H2 2016 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Gallbladder Cancer – Pipeline Review, H2 2016, provides an overview of the Gallbladder Cancer (Oncology) pipeline landscape. Gallbladder cancer is a cancer ...

Nov, 2016 74 pages
2016-2021 US Hospital Cancer Diagnostics Market Forecasts: Supplier Shares, Competitive Landscape, Innovative Technologies, Instrumentation Review US$ 6,500.00

... contains 567 pages, 50 tables, and presents a comprehensive analysis of the US hospital cancer diagnostics market, including: Major issues pertaining to the US laboratory practice, as well ... 40 cancer diagnostic procedures performed in US hospitals. Current instrumentation technologies and feature comparison of leading analyzers. Sales and market shares of leading suppliers. Emerging diagnostic technologies ...

Nov, 2016 567 pages
2016-2021 UK Hospital Cancer Diagnostics Market Forecasts: Supplier Shares, Competitive Landscape, Innovative Technologies, Instrumentation Review US$ 3,850.00

... , 37 tables, and presents a comprehensive analysis of the UK hospital cancer diagnostics market, including: Major issues pertaining to the UK hospital laboratory practice, as well as key economic, regulatory ... 40 cancer diagnostic procedures performed in UK hospitals. Current instrumentation technologies and feature comparison of leading analyzers. Sales and market shares of leading suppliers. Emerging diagnostic technologies ...

Nov, 2016 527 pages
2016-2021 Spain Hospital Cancer Diagnostics Market Forecasts: Supplier Shares, Competitive Landscape, Innovative Technologies, Instrumentation Review US$ 3,850.00

... , and presents a comprehensive analysis of the Spanish hospital cancer diagnostics market, including: Major issues pertaining to the Spanish hospital laboratory practice, as well as key economic ... 40 cancer diagnostic procedures performed in Spanish hospitals. Current instrumentation technologies and feature comparison of leading analyzers. Sales and market shares of leading suppliers. Emerging diagnostic ...

Nov, 2016 521 pages
2016-2021 Japan Hospital Cancer Diagnostics Market Forecasts: Supplier Shares, Competitive Landscape, Innovative Technologies, Instrumentation Review US$ 4,850.00

... , and presents a comprehensive analysis of the Japanese hospital cancer diagnostics market, including: Major issues pertaining to the Japanese hospital laboratory practice, as well as key economic ... 40 cancer diagnostic procedures performed in Japanese hospitals. Current instrumentation technologies and feature comparison of leading analyzers. Sales and market shares of leading suppliers. Emerging diagnostic ...

Nov, 2016 537 pages
2016-2021 Italy Hospital Cancer Diagnostics Market Forecasts: Supplier Shares, Competitive Landscape, Innovative Technologies, Instrumentation Review US$ 3,850.00

... , and presents a comprehensive analysis of the Italian hospital cancer diagnostics market, including: Major issues pertaining to the Italian hospital laboratory practice, as well as key economic ... 40 cancer diagnostic procedures performed in Italian hospitals. Current instrumentation technologies and feature comparison of leading analyzers. Sales and market shares of leading suppliers. Emerging diagnostic ...

Nov, 2016 525 pages
2016-2021 Global Cancer Diagnostics Market Overview: Test Volume and Sales Forecasts by Country, Laboratory Universe US$ 2,450.00

... of the cancer diagnostics market, including mortality statistics and scientific views on the etiology of major types of cancer, estimates of the number of laboratories performing cancer tests, as well ...

Nov, 2016 11 pages
2016-2021 Germany Hospital Cancer Diagnostics Market Forecasts: Supplier Shares, Competitive Landscape, Innovative Technologies, Instrumentation Review US$ 3,850.00

... , and presents a comprehensive analysis of the German hospital cancer diagnostics market, including: Major issues pertaining to the German hospital laboratory practice, as well as key economic ... 40 cancer diagnostic procedures performed in German hospitals. Current instrumentation technologies and feature comparison of leading analyzers. Sales and market shares of leading suppliers. Emerging diagnostic ...

Nov, 2016 533 pages
2016-2021 France Hospital Cancer Diagnostics Market Forecasts: Supplier Shares, Competitive Landscape, Innovative Technologies, Instrumentation Review US$ 3,850.00

... , and presents a comprehensive analysis of the French hospital cancer diagnostics market, including: Major issues pertaining to the French hospital laboratory practice, as well as key economic ... 40 cancer diagnostic procedures performed in French hospitals. Current instrumentation technologies and feature comparison of leading analyzers. Sales and market shares of leading suppliers. Emerging diagnostic ...

Nov, 2016 533 pages
2016-2021 Emerging Cancer Diagnostic Tests and Strategic Assessments of Leading Suppliers US$ 3,500.00

... clinical significance and market needs for both current and emerging cancer diagnostic tests, as well as extensive listings of companies, universities and research centers developing ... applications. The report also presents strategic assessments of current and emerging suppliers of cancer diagnostic products, including their sales, product portfolios, distribution tactics ...

Nov, 2016 286 pages
Penile Cancer Treatment Market: By Cause (HPV, and HIV), By Penile Cancer Type (Squamous Cell Carcinoma, Intraepithelial Neoplasia, Others), By Treatment (Chemotherapy, Antiviral Therapy,... US$ 5,250.00

... has the highest market share in global penile cancer treatment market. This report segments global penile cancer treatment market on the basis of cause, penile cancer type, treatment, and regional market as follows: Penile Cancer Treatment Market, By Cause: Human Papiloma Virus (HPV), and Human Immunodeficiency Virus (HIV) Penile Cancer Treatment Market, By Penile Cancer ...

Jan, 2016 137 pages
Ovarian Cancer Drugs Market: By Types (Epithelial tumor, stromal tumor and germ cell tumors) & By Geography (Europe, Asia Pacific, North America, Rest of the World)-Forecast (2016-2021) US$ 5,250.00

... expiry of several leading drugs, this can act as a restraining factor for the growth of global Ovarian cancer drugs market. Globally market for Ovarian Cancer Drugs The market for ovarian cancer is segmented geographically ... to Ovarian Cancer Drugs market. This report on global Ovarian Cancer Drugs is segmented on the basis of Ovarian Cancer Drugs application, end-use industries using Ovarian Cancer Drugs for wide range of end-use applications and market ...

Feb, 2016 148 pages
Metastatic Breast Cancer Market: By Drugs (Paclitaxel, Tamoxifen, Vinblastine, Raloxifene, Docetaxel), By Treatment (Radiation Therapy, Vitamin Therapy, Macrobiotic Diets, Homeopathy,... US$ 5,250.00

... aspects with respect to global metastatic breast cancer market. This report segments global metastatic breast cancer market on the basis of drugs, treatment, and regional market as follows: Metastatic Breast Cancer Market, By Drugs: Paclitaxel, Tamoxifen, Vinblastine, Raloxifene, Docetaxel and Others Metastatic Breast Cancer Market, By Treatment ...

Jan, 2016 146 pages
Lung Cancer Surgery Market: By Type (Thoracotomy, Minimally Invasive Procedures), By End-User (Hospitals, Adult Lung Cancer Surgery Centers, Ambulatory Surgical Centers) & By... US$ 5,250.00

... lung cancer surgery market on the basis of by type, end-user and regional market as follows: Lung Cancer Surgery Market, By Type: Thoracotomy, Minimally Invasive Procedures (Video-Assisted Thoracoscopic Surgery (Vats), Robotic Surgery) Lung Cancer Surgery Market, End-User: Hospitals, Adult Lung Cancer Surgery Centers ...

Feb, 2016 161 pages
Lip Cancer Market: By Diagnosis Test (computed tomography (CT) scan, MRI scan, positron emission tomography (PET) scan, chest X-ray, complete blood count (CBC)), By Causes (Smoking,... US$ 5,250.00

... market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global lip cancer market. This report segments global lip cancer market on the basis of diagnosis test, causes and regional market as follows: Lip Cancer Market, By Diagnosis tests: computed tomography (CT) scan ...

Jan, 2016 144 pages
Colorectal Cancer Market: By Testing & Diagnosis (Macroscopy, Microscopy, Immunochemistry, Staging, & Tumor Budding); By Therapies & Drugs & By Geography- Analysis & Forecast (2016- 2021) US$ 5,250.00

... the major types of diagnosis and testing method used for detecting colorectal cancer. Macroscopy, microscopy, immunochemistry, staging, ... immunotherapy treatment. Colorectal Cancer Market The report analyzes the key industry factors affecting the colorectal cancer market. The major market dynamic factors such ...

Mar, 2016 161 pages
Cancer Immunotherapy Market: By Cancer Type (Cancer Monoclonal Antibodie, Immune Checkpoint Inhibitors, Cancer Vaccines, Non-Specific Immunotherapies & Others) & Geography-Forecast... US$ 5,250.00

... about cancer and various available treatments to cure cancer are major driving factors for the growth of cancer immunotherapy market. This report identifies the cancer immunotherapy market size ... with respect to cancer immunotherapy market. Globally North America dominated the market for cancer immunotherapy in 2015 with accounting for nearly half of the global market due to high ...

Feb, 2016 142 pages
Cancer Hormone Therapy Market: By Therapy Type (Neoadjuvant & Adjuvant Treatment), By Cancer Treated (Breast, Prostate, Ovarian, Thyroid, Kidney & Other Cancers) & By Geography-Forecast... US$ 5,250.00

... types of cancer. However doctors and surgeons use hormone therapy for people with cancers that are hormone sensitive or hormone dependent. This report identifies the cancer hormone therapy market size ... indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to cancer hormone therapy market. Globally North America dominated the market for cancer hormone therapy in 2015 ...

Feb, 2016 167 pages
Cancer Diagnostics Market: By Product Type (Next-generation Sequencing, Microarrays, PCR, Flow Cytometry, In situ Hybridization, Immunohistochemistry, Imaging Instruments, & Biopsy), By... US$ 5,250.00

... indicators, challenges, market dynamics, competitive landscape, and other key aspects with respect to cancer diagnostics market. Globally North America dominated the market for cancer diagnostics in 2015 ... on global cancer diagnostics also covers different type of cancer diagnostics product available, various cancer treated and market size in various geographical regions. On the basis of type of cancer diagnostics product available, this ...

Feb, 2016 164 pages
Cancer Biomarkers Market: By Product (ELISA pair sets, RNA, Tumor suppressor, cDNA clone, & Others Based), By Type (Protein, Genetic, & Other Biomarkers) By Technology, By Tumor Type, By... US$ 5,250.00

... cancer biomarkers market followed by drug discovery and development. This report segments global cancer biomarkers market on the basis of product, technology, application, end-user, and regional market as follows: Cancer Biomarkers Market, By Product: ELISA pair sets based, RNA based, Tumor suppressor based, cDNA clone based, and Others Cancer Biomarkers Market, By Type: Protein Biomarkers, Genetic Biomarkers ...

Feb, 2016 161 pages
AFP Testing Market: By Cancer Type (Liver Cancer, Testes Cancer, Ovarian Cancer, Biliary Tract Cancer, Stomach Cancer, Pancreatic Cancer, Others (Cirrhosis, and Hepatitis)) &... US$ 5,250.00

... market share amongst all the major regions. This market research report on global alpha-fetoprotein (AFP) Testing market is segmented based on the cancer type, as follows: Liver Cancer, Testes Cancer, Ovarian Cancer, Biliary Tract Cancer, Stomach Cancer, Pancreatic Cancer and ...

Jan, 2016 145 pages
Global Cancer Vaccines Market to 2022 - Robust Growth Driven by Increasing Prevalence, New Therapeutic Vaccine Approvals and Strong Uptake of Treatments Targeting CD19 US$ 4,995.00

Global Cancer Vaccines Market to 2022 - Robust Growth Driven by Increasing Prevalence, New Therapeutic Vaccine Approvals and Strong Uptake of Treatments Targeting CD19 Summary Cancer vaccines ...

Nov, 2016 183 pages
U.S. Clinical Oncology Next Generation Sequencing (NGS) Market Size & Forecast By Technology (Whole Genome Sequencing, Whole Exon Sequencing, Targeted Sequencing & Resequencing), By... US$ 4,950.00

... clinical oncology next generation sequencing market is anticipated to reach USD 1.53 billion by 2024, according to a new report by Grand View Research, Inc. Application of NGS platform for clinical oncology are expected to grow at a steady pace under the influence of increasing adoption of NGS platforms in oncology R&D coupled with rising ...

Oct, 2016 86 pages
Global and Chinese Prostate Cancer Therapeutics Industry, 2016 Market Research Report US$ 2,800.00

The 'Global and Chinese Prostate Cancer Therapeutics Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Prostate Cancer Therapeutics ... project of Prostate Cancer Therapeutics Industry before evaluating its feasibility. Overall, the report provides an in-depth insight of 2011-2021 global and Chinese Prostate Cancer Therapeutics industry ...

Nov, 2016 150 pages
Global and Chinese Lung Cancer Therapeutics Industry, 2016 Market Research Report US$ 2,800.00

The 'Global and Chinese Lung Cancer Therapeutics Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Lung Cancer Therapeutics ... project of Lung Cancer Therapeutics Industry before evaluating its feasibility. Overall, the report provides an in-depth insight of 2011-2021 global and Chinese Lung Cancer Therapeutics industry ...

Nov, 2016 150 pages
Global and Chinese Lung Cancer Surgery Industry, 2016 Market Research Report US$ 2,800.00

The 'Global and Chinese Lung Cancer Surgery Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Lung Cancer Surgery ... project of Lung Cancer Surgery Industry before evaluating its feasibility. Overall, the report provides an in-depth insight of 2011-2021 global and Chinese Lung Cancer Surgery industry ...

Nov, 2016 150 pages
Chondrosarcoma - Pipeline Review, H2 2016 US$ 2,000.00

... pipeline guide Chondrosarcoma – Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Chondrosarcoma (Oncology), complete with analysis by stage of development ...

Nov, 2016 148 pages
India Cervical Cancer Screening Market Outlook 2022 US$ 1,200.00

... India Cervical Cancer Screening Market Outlook 2022” research report discusses all aspects related to the cervical cancer screening market in India. Report gives comprehensive insight on the current accessible cervical screening approaches available in India ...

Nov, 2016 80 pages
Non-Small Cell Lung Cancer Global Clinical Trials Review, H2, 2016 US$ 2,500.00

... clinical trial report, “Non-Small Cell Lung Cancer Global Clinical Trials Review, H2, 2016' provides an overview of Non-Small Cell Lung Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Non-Small Cell Lung Cancer. Report includes an overview of trial ...

Sep, 2016 3400 pages
Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Global Clinical Trials Review, H2, 2016 US$ 2,500.00

Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) Global Clinical Trials Review, H2, 2016' provides an overview of Hodgkin Lymphoma (B-Cell Hodgkin Lymphoma) clinical trials ...

Sep, 2016 782 pages
Global Cancer Nanomedicine Market Outlook 2022 US$ 2,200.00

... Global Cancer Nanomedicine Market Outlook 2022” Report Highlights: Overview & Mechanism of Action of Nanomedicine Nanomedicine Engineering: Design & Strategy Cancer Nanomedicine as Diagnostic & Therapeutics Tool Global Cancer Nanomedicine Market Overview & Dynamics Global Cancer Nanomedicine ...

Nov, 2016 420 pages
Global Cancer Cognitive Computing Market Outlook 2022 US$ 1,500.00

... , it is anticipated that the Global Cancer Cognitive Computing market will cross US$ 4 Billion by 2022. The growth of the market is likely to be driven by advancements in computing platforms, rising installation of cognitive computing software in hospitals, increasing large and complex genomic datasets, and growing cancer incidences. The report, “Global Cancer Cognitive Computing Market Outlook ...

Nov, 2016 100 pages
Thymic Carcinoma - Pipeline Review, H2 2016 US$ 2,000.00

... pipeline guide Thymic Carcinoma – Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Thymic Carcinoma (Oncology), complete with analysis by stage of development ...

Nov, 2016 87 pages
Gliosarcoma - Pipeline Review, H2 2016 US$ 2,000.00

... pipeline guide Gliosarcoma – Pipeline Review, H2 2016, provides comprehensive information on the therapeutics under development for Gliosarcoma (Oncology), complete with analysis by stage of development ...

Nov, 2016 141 pages
Cancer Immunotherapy - Global Market Outlook (2016-2022) US$ 4,150.00

... Global Cancer Immunotherapy market is estimated at $54.35 billion in 2015 and is expected to reach $147.25 billion by 2022 growing at a CAGR of 15.3% from 2015 to 2022. Rapid increase in cases of cancer ... is hampering the market growth. On the other hand rise in clinical trials against different cancers in immunotherapy is the opportunity for the market growth. Monoclonal Antibodies ...

Oct, 2016 157 pages
Cancer Biomarkers - Global Market Outlook (2016-2022) US$ 4,150.00

According to Stratistics MRC, the Global Cancer Biomarkers market is estimated at $9215.32 million in 2015 and is expected to reach $20958.63 million by ... opportunity for the market growth. North America captured huge share in terms of revenue owing to raising awareness towards cancer diagnostics. However, Asia ...

Oct, 2016 133 pages
Market Access Impact: Non-Small Cell Lung Cancer (US) 2016 US$ 4,995.00

... barriers related to market access affect slightly more prescriptions than any other barrier. One brand has a small perception problem: 15% ... Exploring Market Access Barriers Market Access Impact: NSCLC explores key issues affecting NSCLC drug manufacturers. You’ll learn: How barriers affect market access: ...

Sep, 2016
Market Access Impact: Non-Small Cell Lung Cancer (EU5) 2016 US$ 4,995.00

... 3 rival brands managed small barrier-related gains? Which barriers have the biggest impact on market share? Find out in Market Access Impact: NSCLC. Request sample pages ... ) Exploring Important Market Access Issues Market Access Impact: NSCLC explores key issues affecting NSCLC drug manufacturers. You’ll learn: How barriers affect market access: What brands ...

Sep, 2016
Colorectal Cancer KOL Insight 2016 US$ 7,900.00

... with persistently low survival rates, KOLs are calling for new approaches to treat late-stage colorectal cancer (CRC). Some say novel therapies ... to evolve over the next five years in KOL Insight: Colorectal Cancer. You’ll get 12 North American and European KOLs’ candid thoughts on 6 recently marketed CRC treatments ...

Oct, 2016
Global Oncology Biosimilars Sales Market Report 2016 US$ 3,800.00

The global oncology biosimilars market will witness substantial growth over the forecast period and is ... drivers promoting the growth of oncology biosimilars market. The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical ...

Oct, 2016 125 pages
Global Oncology Biosimilars Market Research Report 2016 US$ 2,800.00

... the growth of oncology biosimilars market. The Global Oncology Biosimilars Market Research Report 2016 is a valuable source of insightful data for business strategists. It provides the Oncology Biosimilars industry overview with ... GlaxoSmithKline (GSK) Merck Sanofi and Sandoz. Global Oncology Biosimilars Market: Product Segment Analysis Type I Type II Type III Global Oncology Biosimilars Market: Application Segment Analysis Application I Application ...

Oct, 2016 131 pages
2016 Europe Cancer Diagnostic Testing Analyzers and Reagents in 28 Countries: Supplier Shares and Strategies, Sales Segment Forecasts by Tumor Marker--Oncogenes, Biochemical Markers,... US$ 43,500.00

... their potential applications for cancer diagnostic testing. Review of competing/complementing technologies. Companies, universities and research centers developing new cancer diagnostic tests and detection technologies. Competitive Strategies Strategic assessments of major suppliers and start- up firms developing innovative cancer diagnostic technologies and ...

Oct, 2016 925 pages
Transitional Cell Cancer (Urothelial Cell Cancer) Global Clinical Trials Review, H2, 2016 US$ 2,500.00

... Cell Cancer (Urothelial Cell Cancer) Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Transitional Cell Cancer (Urothelial Cell Cancer) Global Clinical Trials Review, H2, 2016' provides an overview of Transitional Cell Cancer (Urothelial Cell Cancer) clinical trials ...

Aug, 2016 448 pages
T-Cell Lymphomas Global Clinical Trials Review, H2, 2016 US$ 2,500.00

... clinical trial report, “T-Cell Lymphomas Global Clinical Trials Review, H2, 2016' provides an overview of T-Cell Lymphomas clinical trials scenario. This report provides top line data relating to the clinical trials on T-Cell Lymphomas. Report includes an overview of trial ...

Aug, 2016 624 pages
T-Cell Leukemia Global Clinical Trials Review, H2, 2016 US$ 2,500.00

... clinical trial report, “T-Cell Leukemia Global Clinical Trials Review, H2, 2016' provides an overview of T-Cell Leukemia clinical trials scenario. This report provides top line data relating to the clinical trials on T-Cell Leukemia. Report includes an overview of trial ...

Aug, 2016 173 pages
Supratentorial Glioma Global Clinical Trials Review, H2, 2016 US$ 2,500.00

... clinical trial report, “Supratentorial Glioma Global Clinical Trials Review, H2, 2016' provides an overview of Supratentorial Glioma clinical trials scenario. This report provides top line data relating to the clinical trials on Supratentorial Glioma. Report includes an overview of trial ...

Aug, 2016 55 pages
Subependymal Giant Cell Astrocytoma Global Clinical Trials Review, H2, 2016 US$ 2,500.00

Subependymal Giant Cell Astrocytoma Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Subependymal Giant Cell Astrocytoma Global Clinical Trials Review, H2, 2016' provides an overview of Subependymal Giant Cell Astrocytoma clinical trials ...

Aug, 2016 45 pages
1 2 3 4 5 >
Skip to top